This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04657991
Brief Title: A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

First Submitted : December 1, 2020
First Submitted that Met QC Criteria : December 1, 2020
First Posted : December 8, 2020

Last Update Submitted that Met QC Criteria : April 12, 2024
Last Update Posted : April 15, 2024 (Estimate)